Akebia Ther Stock Analysis
AKBA Stock | USD 2.04 0.80 28.17% |
Akebia Ther is overvalued with Real Value of 2.14 and Target Price of 5.5. The main objective of Akebia Ther stock analysis is to determine its intrinsic value, which is an estimate of what Akebia Ther is worth, separate from its market price. There are two main types of Akebia Ther's stock analysis: fundamental analysis and technical analysis.
The Akebia Ther stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Akebia Ther's ongoing operational relationships across important fundamental and technical indicators.
Akebia |
Akebia Stock Analysis Notes
About 29.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.37. Akebia Ther had not issued any dividends in recent years. Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Akebia Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 426 people. For more info on Akebia Ther please contact John MBA at 617 871 2098 or go to https://www.akebia.com.Akebia Ther Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Akebia Ther's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Akebia Ther or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Akebia Ther had very high historical volatility over the last 90 days | |
The company reported the previous year's revenue of 160.18 M. Net Loss for the year was (69.41 M) with profit before overhead, payroll, taxes, and interest of 134.03 M. | |
Akebia Ther currently holds about 143.89 M in cash with (40.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78. | |
Latest headline from gurufocus.com: Akebia Therapeutics Announces Proposed Public Offering of Common Stock |
Akebia Ther Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Akebia Ther previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
14th of March 2024 Upcoming Quarterly Report | View | |
13th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
14th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Akebia Largest EPS Surprises
Earnings surprises can significantly impact Akebia Ther's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-08-08 | 2024-06-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2024-05-09 | 2024-03-31 | -0.08 | -0.09 | -0.01 | 12 | ||
2025-03-12 | 2024-12-31 | -0.075 | -0.1 | -0.025 | 33 |
Akebia Ther Environmental, Social, and Governance (ESG) Scores
Akebia Ther's ESG score is a quantitative measure that evaluates Akebia Ther's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Akebia Ther's operations that may have significant financial implications and affect Akebia Ther's stock price as well as guide investors towards more socially responsible investments.
Akebia Stock Institutional Investors
Shares | Connor Clark & Lunn Inv Mgmt Ltd | 2024-12-31 | 1 M | Goldman Sachs Group Inc | 2024-12-31 | 1 M | Federated Hermes Inc | 2024-12-31 | 914 K | Fmr Inc | 2024-12-31 | 747 K | Charles Schwab Investment Management Inc | 2024-12-31 | 586.7 K | Susquehanna International Group, Llp | 2024-12-31 | 586.1 K | Bank Of America Corp | 2024-12-31 | 543.9 K | Wellington Management Company Llp | 2024-12-31 | 502.1 K | Bank Of New York Mellon Corp | 2024-12-31 | 497.5 K | Blackrock Inc | 2024-12-31 | 15.1 M | Vanguard Group Inc | 2024-12-31 | 10.9 M |
Akebia Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 670.9 M.Akebia Profitablity
The company has Profit Margin (PM) of (0.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.22) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.22.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.43) | (0.45) | |
Return On Capital Employed | (0.36) | (0.38) | |
Return On Assets | (0.31) | (0.33) | |
Return On Equity | 1.41 | 1.48 |
Management Efficiency
Akebia Ther has return on total asset (ROA) of (0.1249) % which means that it has lost $0.1249 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.5345) %, meaning that it created substantial loss on money invested by shareholders. Akebia Ther's management efficiency ratios could be used to measure how well Akebia Ther manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 1.48, whereas Return On Tangible Assets are forecasted to decline to (0.45). At present, Akebia Ther's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 12.6 M, whereas Total Current Assets are forecasted to decline to about 108.1 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.23) | (0.22) | |
Tangible Book Value Per Share | (0.51) | (0.49) | |
Enterprise Value Over EBITDA | (25.69) | (24.40) | |
Price Book Value Ratio | (8.15) | (7.74) | |
Enterprise Value Multiple | (25.69) | (24.40) | |
Price Fair Value | (8.15) | (7.74) | |
Enterprise Value | 352.5 M | 394 M |
Akebia Ther's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Technical Drivers
As of the 21st of March, Akebia Ther shows the mean deviation of 3.23, and Risk Adjusted Performance of 0.1232. Akebia Ther technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Akebia Ther Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Akebia Ther middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Akebia Ther. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Akebia Ther Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Akebia Ther insiders, such as employees or executives, is commonly permitted as long as it does not rely on Akebia Ther's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Akebia Ther insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Akebia Ther Outstanding Bonds
Akebia Ther issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Akebia Ther uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Akebia bonds can be classified according to their maturity, which is the date when Akebia Ther has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Akebia Ther Predictive Daily Indicators
Akebia Ther intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Akebia Ther stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Akebia Ther Corporate Filings
20th of March 2025 Other Reports | ViewVerify | |
19th of March 2025 Other Reports | ViewVerify | |
8K | 13th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
14th of February 2025 Other Reports | ViewVerify | |
8K | 7th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
30th of January 2025 Other Reports | ViewVerify |
Akebia Ther Forecast Models
Akebia Ther's time-series forecasting models are one of many Akebia Ther's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Akebia Ther's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Akebia Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Akebia Ther prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Akebia shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Akebia Ther. By using and applying Akebia Stock analysis, traders can create a robust methodology for identifying Akebia entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.43) | (0.45) | |
Operating Profit Margin | (0.32) | (0.33) | |
Net Loss | (0.43) | (0.45) | |
Gross Profit Margin | 0.61 | 0.64 |
Current Akebia Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Akebia analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Akebia analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
5.5 | Strong Buy | 3 | Odds |
Most Akebia analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Akebia stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Akebia Ther, talking to its executives and customers, or listening to Akebia conference calls.
Akebia Stock Analysis Indicators
Akebia Ther stock analysis indicators help investors evaluate how Akebia Ther stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Akebia Ther shares will generate the highest return on investment. By understating and applying Akebia Ther stock analysis, traders can identify Akebia Ther position entry and exit signals to maximize returns.
Begin Period Cash Flow | 44.6 M | |
Long Term Debt | 38.7 M | |
Common Stock Shares Outstanding | 210.9 M | |
Total Stockholder Equity | -49.2 M | |
Property Plant And Equipment Net | 10.4 M | |
Cash And Short Term Investments | 51.9 M | |
Cash | 51.9 M | |
Accounts Payable | 15.2 M | |
Net Debt | -48.3 M | |
50 Day M A | 2.0561 | |
Total Current Liabilities | 80.9 M | |
Other Operating Expenses | 210.7 M | |
Non Current Assets Total | 106.8 M | |
Non Currrent Assets Other | 37.4 M | |
Stock Based Compensation | 7.8 M |
Complementary Tools for Akebia Stock analysis
When running Akebia Ther's price analysis, check to measure Akebia Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Ther is operating at the current time. Most of Akebia Ther's value examination focuses on studying past and present price action to predict the probability of Akebia Ther's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Ther's price. Additionally, you may evaluate how the addition of Akebia Ther to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |